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METHODS: Records of 62,003 obstetrical deliveries
were extracted from a Nationwide Inpatient Sample of
the Healthcare Cost and Utilization Project data (DRG
371 for cesarean delivery without complications and 373
for vaginal delivery without complications). Regression
analyses were conducted to predict maternity LOS and
total charges based on type of delivery, age, race, number
of diagnoses at discharge, primary payer (Medicaid,
private insurance/HMO, self-pay, other), and hospital
characteristics of bed size, region (northeast, midwest,
south, west), location (rural, urban), teaching status, and
control/ownership.
RESULTS: In 1997, 82% of the deliveries were vaginal
while 18% were cesarean. Average LOS for vaginal and
cesarean deliveries was 1.86 and 3.36 days, respectively.
Mean total charges for vaginal deliveries were $3,778 as
compared to $7,243 for cesarean deliveries. Regression
results indicate that type of delivery was the strongest pre-
dictor of LOS and total charges. Women with a cesarean
delivery stayed on an average 1.3 days more in the 
hospital and incurred 64% more charges than women
with vaginal delivery. For vaginal delivery, an additional
day of hospitalization increased total charges by 12.4% 
as compared to 6.7% for cesarean delivery. Medicaid
patients had shorter LOS than private insurance/HMOs,
and longer LOS than self-paying patients. Northeast hos-
pitals had greater LOS while hospitals in the West had
higher charges. Urban hospitals and teaching hospitals
had higher LOS and charges.
CONCLUSIONS: Signiﬁcant variations in maternity LOS
and total charges were observed on the basis of type 
of delivery and hospital-related characteristics, which
warrant further investigation. Additionally, the impact of
LOS and total charges on mother and infant morbidity
should be explored.
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Urinary problems secondary to benign prostatic hyper-
plasia (BPH) are found in 20 to 25% of the population
of men over 50 years of age. This is thus a public health
problem with a number of diagnostic, therapeutic and
economic facets. The severity of the problem is assessed
by the score obtained on the IPSS, a well known and
recognised questionnaire.
OBJECTIVE: As part of the growing importance attached
to the care giver, it is interesting to evaluate the conse-
quences of this masculine pathology for the spouse.
METHOD: As part of a cohort study (October
2000–March 2001), the GP gave the patient 2 «PFM»
(Patient Family Measurement) self-questionnaires for
himself and his spouse. For the analysis, 357 patient ques-
tionnaires and 316 spouse questionnaires were analysed.
The rate of return of the spouse questionnaires (88%) was
very satisfactory. The quality of life (QOL) of the patient
was measured by the SF12; the results consisted of 2
scores: mental (MCS-12) and physical (PCS-12).
RESULTS: The norm observed in the American popu-
lation, and from which the scores were standardised, 
was 50. In the patient where the QOL had deteriorated,
all the scores were lower than this norm, (PCS-12 = 46
& MCS-12 = 47.2). This deterioration in the quality of
life also applied to the spouse. (PCS-12 = 44.4 & 
MCS-12 = 45.9). For the PCS-12, the difference was 
signiﬁcant.
CONCLUSION: The rate of return of the spouse ques-
tionnaires showed the interest and involvement of spouses
in their husband’s pathology. The deterioration in the
quality of life of the spouse highlighted the impact of 
the disease on those around him. In both the patient 
and the spouse, the quality of life deteriorated with the
severity of the BPH.
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Urinary problems secondary to benign prostatic hyper-
plasia (BPH) are found in 20 to 25% of the population
of men over 50 years of age. This is thus a public health
problem with a number of diagnostic, therapeutic and
economic facets. Severity of the problem is assessed by
the score obtained on the IPSS, a well known and 
recognised questionnaire.
OBJECTIVE: As part of the growing importance attached
to the care giver, to evaluate the impact of this masculine
pathology upon the spouse.
METHOD: As part of a cohort study (10/2000–03/
2001), the GP gave the patient two «PFM» (Patient
Family Measurement) self-questionnaires for himself and
his spouse. During the consultation, 36.1% of the
patients spontaneously complained of sleep problems.
RESULTS: We are most interested in the impact of
daytime somnolence. The Epworth Scale was used to
evaluate this. The score observed in a control population
with normal sleeping habits is 5.9. For the analysis, we
analysed 482 patient questionnaires and 382 spouse ques-
tionnaires. The rate of return of the spouse questionnaires
(80%) was very satisfactory. For the patient, the risk of
daytime somnolence was made worse by the severity of
the urinary problem (slight—moderate—severe = 5.9–
6.4–8.9). For the spouses, the score rose to 5.2. For the
spouses, depending on the severity group slight—
moderate—severe of their husbands, the score rose to
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4.7–5–7.4. There is therefore a signiﬁcant risk of daytime
somnolence among spouses of patients with severe BPH.
CONCLUSION: As it is known that somnolence is
responsible for a third of all road accidents, it is essential
for these patients to limit the severity of their pathology
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OBJECTIVE: An epidemiological study on migraine was
conducted in France in 2000. This general population
study—GRIM 2000—was among others designed to eval-
uate the socio-economic impact of migraine.
METHODS: In a sample of 10,585 subjects over the age
of 15 years, representative of the French population,
1,486 people suffering from headache were interviewed.
Part of the questionnaire concerned consumption of
medical resources and loss of productivity.
RESULTS: 880 of the 1,486 subjects complaining of
headache were found to suffer from migraine (according
to IHS criteria 1-1, 1-2, and 1-7). Migraine patients had
consulted their general practitioner an average of three
times during the previous 6 months. Seventy percent of
these patients systematically took medication to relieve
their headache and they also reported that they always
took the same treatment. The medications most fre-
quently (90%) used were analgesics and non-steroidal
anti-inﬂammatory drugs. 4% of migraine patients took
triptans. 8% of migraineurs took a prophylactic treat-
ment for their headaches. The complementary investiga-
tions most frequently performed were ophthalmic
examinations (16%). Only seven subjects had been hos-
pitalised for their migraine attacks during the previous 6
months, with an average length of stay of 2.3 days.
Migraine patients were absent from work twice as often
as non-migraine headache patients, with an average of 6
days of absence during the previous 3 months. Finally, a
strong correlation was observed between severity of the
attack and consumption of medical resources (particu-
larly medications and visits to the doctor).
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OBJECTIVES: X-rays are frequently used as the initial
imaging study for low back pain (LBP). X-rays are inex-
pensive, but neither sensitive nor speciﬁc for many causes
of LBP. Recently developed rapid magnetic resonance
(RMR) imaging protocols provide more accurate anat-
omical information. Furthermore, because of reduced
imaging time, RMR cost may approach that of X-ray. We
conducted a randomized controlled trial measuring the
societal perspective cost-effectiveness of RMR versus 
X-ray for patients with LBP.
METHODS: Patients with lumbar x-rays ordered in 
one of four clinical centers were eligible. Consenting 
subjects were randomized to X-ray or RMR. The primary
outcome was functional status (Roland scale) at 12
months. Economic outcomes included time trade-off
(TTO), visual analogue scale (VAS), and SF-36 derived
utility. Costs of RMR and X-ray imaging were deter-
mined in time-motion studies. Other health care and non-
health care costs were measured using medical record
review and questionnaires and valued using standard unit
costs.
RESULTS: 380 patients were randomized. Functional
outcomes and cost data were available for 328 (86%) and
362 (95%) patients respectively. At 12 months the mean
function of both groups had improved, but there was no
difference between groups (X-ray 4.0 versus RMR 3.9; 
p = 0.939). Likewise, there was no effect on VAS or SF-
36 derived utilities. RMR patients had greater improve-
ment in TTO scores (10.9 versus 3.2; p = 0.026). Health
care costs following RMR were higher with borderline
signiﬁcance ($2154 versus $1638; p = 0.075), principally
due to more specialist consultations and surgery. X-ray
dominated RMR in the primary analysis.
CONCLUSIONS: Our results suggest that the extra cost
of RMR does not result in improved functional status and
currently it should not replace X-ray in clinical practice.
Given the poor correlation between TTO and other 
outcomes, the difference in TTO outcomes is probably a
spurious ﬁnding but warrants further study.
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